Related Experiment Video
Updated: Oct 25, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Targeted lactate depletion via gluconeogenesis by engineered hepatocyte-based micronanorobots for radiosensitization
Yueyue Fan1, Jiamin Ye1, Yuanfang Chen2
1Medical Metabolomics Center, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China; Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Abstract:
Radiotherapy is often limited by tumor-intrinsic DNA repair and an immunosuppressive microenvironment, both of which are reinforced by lactate accumulation. Here, we develop a CXCR4-engineered enucleated hepatocyte cytoplast platform decorated with Au-Pt Janus nanorobots (AP/LCCXCR4) to deplete intratumoral lactate and amplify radiation-induced oxidative stress. The hepatocyte cytoplasts home to tumors and consume lactate through gluconeogenesis, reducing repair-associated protein lactylation and impairing MRE11-RAD50-NBS1 (MRN) co-fractionation and chromatin recruitment, thereby impairing double-strand break repair. In parallel, the Au-Pt nanorobots enhance reactive oxygen species generation under acidic tumor conditions, increasing radiation damage. In radioresistant colorectal cancer models and a metastatic cervical cancer model, AP/LCCXCR4 combined with radiotherapy sustains DNA damage, promotes immunogenic cell death, reduces immunosuppressive myeloid and regulatory T (Treg) cell populations, enhances dendritic cell maturation and CD8+ T cell activation, and improves tumor control and survival.
